TTWM
TEVA icon

TCV Trust & Wealth Management’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

TCV Trust & Wealth Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-16,000
Closed -$120K – 195
2022
Q2 		$120K Hold
16,000
– – 0.01% 196
2022
Q1 		$150K Hold
16,000
– – 0.02% 204
2021
Q4 		$128K Buy
+16,000
New +$144K 0.01% 207
2014
Q2 		– Sell
-3,980
Closed -$210K – 176
2014
Q1 		$210K Sell
3,980
-4,125
-51% -$191K 0.04% 164
2013
Q4 		$325K Sell
8,105
-69,699
-90% -$2.74M 0.06% 138
2013
Q3 		$2.94M Sell
77,804
-1,438
-2% -$56.1K 0.57% 59
2013
Q2 		$3.11M Buy
+79,242
New +$3.09M 0.64% 55

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

TCV Trust & Wealth Management's TEVA Position: Q3 2022 in Review

TCV Trust & Wealth Management sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q3 2022, closing a stake of 16,000 shares — an estimated $120K sold.

TCV Trust & Wealth Management first reported a position in TEVA in Q2 2013 and held it in 7 quarters. The position peaked at $3.11M in Q2 2013. 430 funds tracked by Wall St. Rank hold TEVA as of Q3 2022.

  • TCV Trust & Wealth Management reported no remaining Teva Pharmaceutical Industries Limited position as of Q3 2022 after selling out during the quarter.
  • TCV Trust & Wealth Management sold 16,000 Teva Pharmaceutical Industries Limited shares in Q3 2022, an estimated $120K.
  • TCV Trust & Wealth Management first reported a position in Teva Pharmaceutical Industries Limited in Q2 2013 and held it in 7 quarters.
  • TCV Trust & Wealth Management's Teva Pharmaceutical Industries Limited position peaked at $3.11M in Q2 2013.
  • 430 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q3 2022.

Based on TCV Trust & Wealth Management's 13F filing for Q3 2022, filed 31 Oct 2022.